Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V99.9.3083PMID 11964269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease

  2001cited by this paper
• Ex vivo photodynamic purging in chronic myelogenous leukaemia and other neoplasias with rhodamine derivatives

  1999cited by this paper
• Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta.

  1999cited by this paper
• Depletion of alloreactive T cells by a specific anti-interleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity.

  1999cited by this paper
• Transplantation of anergic histoincompatible bone marrow allografts.

  1999cited by this paper
• CD4(+) T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses.

  1998cited by this paper
• Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactions

  1998cited by this paper
• Dendritic cells and the control of immunity

  1998cited by this paper
• T helper 2-dominant antilymphoma immune response is associated with fatal outcome.

  1997cited by this paper
• Mechanisms of the Graft‐versus‐Leukemia Reaction

  1997cited by this paper
• Eliminating graft-versus-host potential from T cell immunotherapeutic populations.

  1996cited by this paper
• Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool.

  1996cited by this paper
• Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation.

  1996cited by this paper
• Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.

  1995cited by this paper
• Principles of graft-vs.-leukemia reactivity.

  1995cited by this paper
• Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination.

  1994cited by this paper
• Bone marrow transplantation.

  1994cited by this paper
• Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific anti-interleukin-2 receptor Bk chain immunotoxin.

  1993cited by this paper
• Cytokine dysregulation and acute graft-versus-host disease.

  1992cited by this paper
• SPECIFIC ELIMINATION OF ALLOREACTIVE T CELLS BY AN ANTI‐INTERLEUKIN-2 RECEPTOR B CHAIN‐SPECIFIC IMMUNOTOXIN

  1990cited by this paper
• Immunobiology of a Spontaneous Murine B Cell Leukemia (BCL1)

  1979cited by this paper
• Spontaneous murine B-cell leukaemia

  1978cited by this paper
• Bone marrow transplantation.

  1977cited by this paper

• Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect

  2022cites this paper
• Secure transplantation by tissue purging using photodynamic therapy to eradicate malignant cells.

  2022cites this paper
• Photodepletion with 2-Se-Cl prevents lethal graft-versus-host disease while preserving antitumor immunity

  2020cites this paper
• Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis

  2019cites this paper
• Gene and Cell Therapy: Biology and Applications

  2018cites this paper
• SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.

  2018cites this paper
• Haploidentical Stem Cell Transplantation

  2018cites this paper
• Novel Cellular Therapeutic Approaches for the Prevention and Management of Graft-Versus-Host Disease

  2018cites this paper
• Photodepletion to Promote Immune Reconstitution Without Graft-Versus-Host Disease After HLA-Haploidentical Transplantation

  2018cites this paper
• Modern approaches to HLA-haploidentical blood or marrow transplantation.

  2016cites this paper
• Modern approaches to HLA-haploidentical blood or marrow transplantation

  2016cites this paper
• Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives.

  2016cites this paper
• Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease

  2016cites this paper
• Progress in Haploidentical Hematopoietic Stem Cell Transplantation

  2015cites this paper
• "No donor"? Consider a haploidentical transplant.

  2015cites this paper
• Inhibitory effects of merocyanine 540-mediated photodynamic therapy on cellular immune functions: A role in the prophylaxis of graft-versus-host disease?

  2015cites this paper
• Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin

  2015cites this paper
• Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update

  2015cites this paper
• Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis

  2014cites this paper
• Antiviral T‐cell therapy

  2014cites this paper
• Recent advances in haploidentical stem cell transplantation.

  2013cites this paper
• The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success

  2013cites this paper
• Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use.

  2013cites this paper
• reconstitution after haploidentical stem cell transplant Adoptive immunotherapy with allodepleted donor T-cells improves immune

  2013cites this paper
• Antigen Presentation and Antigen-presenting Cells in Graft-versus-host Disease

  2013cites this paper
• alloreactive T cells from anti-leukemic and anti-tumor donor T-cell lines Targeting the activation-induced antigen CD137 can selectively deplete

  2013cites this paper
• Novel approaches for the isolation and expansion of cytomegalovirus-specific T cells for adoptive immunotherapy

  2013cites this paper
• Effects of ICOSLG expressed in mouse hematological neoplasm cell lines in the GVL reaction

  2013cites this paper
• Selective depletion of alloreactive donor T cells leads to elimination of graft-versus-host reactivity and stimulates graft-versus-leukaemia/myeloma effect.

  2013cites this paper
• In-vitro Generation of potent T-lymphoid Progenitors in a feeder-cell-free DL-4 system

  2012cites this paper
• Cellular Therapy for Hematology Malignancies: Allogeneic Hematopoietic Stem Transplantation, Graft-Versus-Host Disease, and Graft Versus Leukemia Effects

  2012cites this paper
• Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses

  2012cites this paper
• CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.

  2012cites this paper
• Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation.

  2012cites this paper
• Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT

  2012cites this paper
• Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation.

  2011cites this paper
• Modifications of Optical Properties of Blood during Photodynamic Reactions In vitro and In vivo

  2011cites this paper
• Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

  2011cites this paper
• Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

  2011cites this paper
• Targeting of T/Tn Antigens with a Plant Lectin to Kill Human Leukemia Cells by Photochemotherapy

  2011cites this paper
• Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation

  2010cites this paper
• Haploidentical Transplantation for Leukemia

  2010cites this paper
• Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation.

  2010cites this paper
• Identification and selective depletion of alloreactive T-cells for adoptive immunotherapy.

  2010cites this paper
• Advances in adoptive immunotherapy to accelerate T-cellular immune reconstitution after HLA-incompatible hematopoietic stem cell transplantation.

  2010cites this paper
• Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity

  2010cites this paper
• Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease.

  2010cites this paper
• The Challenge in Hematopoietic Stem Cell Transplantation: Shortening the Immunodeficiency Period

  2010cites this paper
• Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy.

  2010cites this paper
• Alloanergization in haploidentical hematopoietic stem cell transplantation

  2010cites this paper
• Hematopoietic Stem Cell Transplantation Across Genetic Barriers Using a Nonmyeloablative Conditioning Regimen

  2010cites this paper
• Selective allodepletion to improve anti-viral and anti-leukaemic responses after haploidentical transplantation

  2009influential citation
• Mouse models of graft-versus-host disease

  2009cites this paper
• Shortening the immunodeficient period after hematopoietic stem cell transplantation

  2009cites this paper
• The Role of Oral Beclometasone Dipropionate in the Treatment of Gastrointestinal Graft-versus-Host Disease

  2009cites this paper
• The BMT Data Book

  2009cites this paper
• Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host disease.

  2009cites this paper
• Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand1

  2009cites this paper
• Treatment with Soluble Fas Ligand VivoDisease-Mediating Human T Cells by Ex Selective Reduction of Graft-versus-Host

  2009influential citation
• Stem Cell Sources for Allogeneic Transplantation

  2008cites this paper
• Understanding and harnessing the graft‐versus‐leukaemia effect

  2008cites this paper
• T cell therapy in allogeneic stem cell transplantation.

  2008cites this paper
• Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.

  2008cites this paper
• Selective Depletion of Alloreactive T Lymphocytes Using Patient-Derived Nonhematopoietic Stimulator Cells in Allograft Engineering

  2008cites this paper
• Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.

  2008cites this paper
• Pathophysiology of Acute Graft-vs-Host Disease: Recent Advances

  2008cites this paper
• A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique.

  2008cites this paper
• Surgical Therapy for Atrial Fibrillation

  2008cites this paper
• Haploidentical Stem Cell Transplantation

  2008cites this paper
• Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.

  2008cites this paper
• Pro‐tolerogenic effects of photodynamic therapy with TH9402 on dendritic cells

  2008cites this paper
• Induction of Alloanergy in Human Donor T Cells Without Loss of Pathogen or Tumor Immunity

  2008cites this paper
• Graft Manipulation: T Cell Depletion and Tumor Cell Purging

  2008cites this paper
• Reconstitution of FOXP 3 regulatory T cells ( Tregs ) after CD 25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease

  2007cites this paper
• Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.

  2007cites this paper
• SUBSPECIALTY IN TRANSLATIONAL MEDICINE of acute graft-versus-host disease: recent advances

  2007cites this paper
• Pathophysiology of acute graft-versus-host disease: recent advances.

  2007cites this paper
• Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

  2007cites this paper
• Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?

  2007cites this paper
• Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.

  2007cites this paper
• Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation.

  2006cites this paper
• Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes

  2006cites this paper
• Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease

  2006cites this paper
• Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.

  2006cites this paper
• Prophylaxis and treatment of acute graft-versus-host disease.

  2006cites this paper
• Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation

  2006cites this paper
• Shared biology of GVHD and GVT effects: potential methods of separation.

  2006cites this paper
• Current status of haploidentical stem cell transplantation

  2006cites this paper
• Mesenchymal stem cells in immunoregulation

  2006cites this paper
• Corticosteroids versus other single drugs or drug combinations for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation

  2006cites this paper
• 1041. Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease

  2006cites this paper
• Allogeneic graft-versus-tumor effects: Mechanistic insights and therapeutic promise

  2005cites this paper
• CD4+CD25+ regulatory T cells in hematopoietic stem cell transplantation.

  2005cites this paper
• Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.

  2005cites this paper
• The influence of photodynamic therapy on the immune response.

  2005cites this paper
• Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

  2005cites this paper
• Selective depletion strategies in allogeneic stem cell transplantation.

  2005cites this paper
• Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?

  2005cites this paper
• Elimination of alloreactive T cells using photodynamic therapy.

  2005cites this paper
• Non-pharmacologic approaches to graft-versus-host prevention.

  2005cites this paper